Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma

Karla B. Anaya Aldrete, Mary A. Ndiaye, Glorimar Guzmán-Pérez, Gabriella R. Zaemisch, Chandra K. Singh, Gagan Chhabra, Nihal Ahmad

Open source

DOI
10.1080/29944376.2026.2656032
Published
2026-04-14
Container
Journal of Dermato-Oncology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/29944376.2026.2656032,
  title = {Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma},
  author = {Karla B. Anaya Aldrete and Mary A. Ndiaye and Glorimar Guzmán-Pérez and Gabriella R. Zaemisch and Chandra K. Singh and Gagan Chhabra and Nihal Ahmad},
  year = {2026},
  journal = {Journal of Dermato-Oncology},
  doi = {10.1080/29944376.2026.2656032},
  url = {https://doi.org/10.1080/29944376.2026.2656032}
}

RIS

TY  - JOUR
TI  - Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma
AU  - Karla B. Anaya Aldrete
AU  - Mary A. Ndiaye
AU  - Glorimar Guzmán-Pérez
AU  - Gabriella R. Zaemisch
AU  - Chandra K. Singh
AU  - Gagan Chhabra
AU  - Nihal Ahmad
PY  - 2026
JO  - Journal of Dermato-Oncology
DO  - 10.1080/29944376.2026.2656032
UR  - https://doi.org/10.1080/29944376.2026.2656032
ER  - 

APA

Aldrete, K. B. A., Ndiaye, M. A., Guzmán-Pérez, G., Zaemisch, G. R., Singh, C. K., Chhabra, G., & Ahmad, N. (2026). Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma. Journal of Dermato-Oncology. https://doi.org/10.1080/29944376.2026.2656032

Source records